PE/VC  NMT Capital

http://www.nmtcapital.com





     Office Locations:

400 Crown Colony Drive, Suite 104
Quincy, MA 02169
Phone: 617-472-2805
Fax: 617-472-3531

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    NMT Capital (formerly Nexus) is a globally oriented private equity firm. It is currently managing three investment funds: two based in Europe and one in the U.S., and its portfolio companies are located in both continents. They are carefully selected from among a wide universe of potential investment opportunities to possess the best technology or business strategy available globally. Founded in 2004 as Nexus Medical Partners, Nexus has expanded its investment strategy to include IT investments as well. It is managed by three Principals who are supported by Advisors and affiliates in Quincy (MA), San Francisco, London, Munich, Geneva and Tokyo. The Principals of Nexus have experience investing in companies in various stages of development, across sectors including medical devices, diagnostics, biotechnology, specialty pharmaceutical, drug discovery tools, software, communications and information technology and advanced materials. The firm is active globally and will consider not only domestic investments, but also offshore (ex-US) investments in companies located in Europe and the Middle East who are seeking to penetrate the U.S. market.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Edwin Snape Ph.D. Co-Founder
    Gregory F. Zaic Principal
    John F. Rousseau Co-Founder & Principal
    Thomas E. Hancock Principal

     

    Portfolio companies include:


      A&G Pharmaceutical
        web link


      Aethon
        web link


      Biodel
        web link


      Cequent Pharmaceuticals
        web link


      Cutanea Life Sciences
        web link


      Deltex Medical
        web link


      EffRx
        web link


      Energetiq Technology
        web link


      EyeGate Pharmaceuticals
        web link


      Kiyatec
        web link


      Lab 21
        web link


      Magellan Biosciences
        web link


      Medivance
        web link


      Mini-Lap Technologies
        web link


      mtm Laboratories
        web link


      Myconostica
        web link


      MyoScience
        web link


      Neurotech
        web link


      NuvoLase
        web link


      PathoLase
        web link


      Presidio Pharmaceuticals
        web link


      Proterra
        web link


      Sabal Medical
        web link


      Spectra Analysis
        web link


      Sultan Scientific
        web link


      Vital Sensors
        web link


      Zipit Wireless
        web link


     

    Recent News:


      There is no recent news for NMT Capital.